The biotechnology startup Editas Medicine intends to begin tests of a powerful new form of gene repair in humans within two years. Speaking this week at the EmTech conference in Cambridge, Massachusetts, Editas CEO Katrine Bosley said the company hopes to start a clinical trial in 2017 to treat a rare form of blindness using CRISPR, a groundbreaking gene-editing technology.
If Editas’s plans move forward, the study would likely be the first to use CRISPR to edit the DNA of a person. CRISPR technology was invented just three years ago but is so precise and cheap to use it has quickly spread through biology laboratories. Already, scientists have used it to generate genetically engineered monkeys, and the technique has stirred debate over whether modified humans are next (see “Engineering the Perfect Baby”)
Credit to skywatchtv.com
http://skywatchtv.com/2015/11/10/crispr-gene-editing-as-featured-in-upcoming-documentary-inhumam-to-be-tested-on-people/
No comments:
Post a Comment